file_name,case_name,docket_number,Granted,Argued,Decided,first_party,first_party_label,second_party,second_party_label,winning_party,decision_type,majority_vote,minority_vote,john_g_roberts_jr,antonin_scalia,anthony_m_kennedy,clarence_thomas,ruth_bader_ginsburg,stephen_g_breyer,samuel_a_alito_jr,sonia_sotomayor,elena_kagan,advocate_ID_0,advocate_0,advocate_description_0,advocate_ID_1,advocate_1,advocate_description_1,advocate_ID_2,advocate_2,advocate_description_2
2011.10-844,"Caraco Pharmaceutical Laboratories, Ltd. v. Novo Nordisk A/S",10-844,1309150800,1323064800,1334638800,"Caraco Pharmaceutical Laboratories, Ltd., et al.",Petitioner,"Novo Nordisk A/S, et al.",Respondent,"Caraco Pharmaceutical Laboratories, Ltd., et al.",majority opinion,9,0,majority,majority,majority,majority,majority,majority,majority,majority,majority,30681,james_f_hurst,for the petitioners,17700,benjamin_j_horwich,"Assistant to the Solicitor General, Department of Justice, as amicus curiae, supporting the petitioners",36483,mark_a_perry,for the respondents
